Karachi: Drug Regulatory Authority of Pakistan (DRAP) recently issued a notification to recall all the stocks of several medicines as glass particles were found in them. The drugs were termed as ‘Adulterated and Sub-Standard’ by the regulatory authority.
An official document released by DRAP read that manufacturers should alert their sales officers/suppliers/ distributors to issue instructions to the pharmacies/hospitals, point of sales/purchase/use for the return of suspected stocks of product in question. “Furthermore, you are directed to submit a compliance report of recall to this division within seven (07) days positively,” the notification read.
The medicines recalled due to contamination of glass particles are the following:
| S No. | Generic Name | Drug Name | Manufacturer |
| 1 | Xylop 1% injection | Kanbact 500mg Injection | Kanel Pharmaceuticals, Islamabad |
| 2 | Oxiphin | Oxiphin 1gm injection | Kannel Pharmaceuticals, Islamabad |
| 3 | Oxiphin | Oxiphin 1gm injection | Ameer and Adnan Pharmaceuticals (Pvt.) Ltd., Lahore |
| 4 | Xylop 1% injection | Kanbact 500mg Injection | Palpex Pharmaceuticals (Pvt.) Ltd., Karachi |
| 5 | Diclofenac | Fenacold injection | Epoch Pharmaceuticals, Karachi |
| 6 | Metronidazole | Flazol Infusion 500mg/l00ml | Bosch Pharmaceuticals, Karachi |
Meanwhile, Remdesivir, a crucial medicine used in treatment against coronavirus, was also recalled by DRAP.
Redzi l00mg Solution for infusion (Remdesivir 5mg/ml) manufactured by WNSFEILD Pharmaceuticals was reportedly found to have bacterial contamination.
-DN Report
